<?xml version="1.0" encoding="UTF-8"?>
<p id="para170">Through our survey and access to CEPI data, we collected new, confidential epidemic infectious disease vaccine research and development cost data. In total, we compiled a set of 138 vaccine research and development cost entries, associated with non-clinical, clinical, process development, and manufacturing activities (
 <xref rid="sec1" ref-type="sec">appendix</xref>). We checked for consistency between our survey data and CEPI's own data on vaccine research and development budgets prior to merging into a single database (
 <xref rid="sec1" ref-type="sec">appendix</xref>). This dataset excludes costs associated with basic laboratory research activities, phase 2b–3 efficacy testing, and stockpiles of investigational material for phase 2b–3 studies.
</p>
